Singapore · Biotechnology

Eywa Pharma

Eywa Pharma, a global generic pharmaceutical company, has been founded by a group of seasoned professionals.

PrivateFor profit

BiotechnologySingapore

Against its peers

Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.

Staff101-250Larger than the typical peer (11-50)
Founded20154 years after the typical peer (2011)
Website traffic#12.7MQuieter than the typical peer's site (#8.6M)

Across all 5.9M companies: larger than 85% of those with a size listed; older than 5% of those with a founding year; website ranked #12,748,344 in the world, about 83 visits a month.

About Eywa Pharma

What it does

BiotechnologyHealth CareManufacturingMedicalPharmaceutical

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$30M

raised in total, currency not stated across 2 rounds

Last raised Jan 2019, 7 years ago

Rounds
2
Latest round
Series unknown
Investors
61 leading

Key facts

Who started it and how it trades.

Founded by
Jayakumar Ramamoorthy, Srinivasan Seshan

Every detail we hold

Everything the source datasets list about Eywa Pharma, field by field. Contact details are held but never shown.

The company7 fields

Name
Eywa Pharma
Type
For profit
Status
Private
Founded
2015
Founders
Jayakumar Ramamoorthy, Srinivasan Seshan
Industry
Biotechnology
Categories
Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical

Where2 fields

Country
Singapore
Markets
Asia-Pacific (APAC)

Size and reach3 fields

Staff band
101-250
Web traffic rank
#12,748,344
Monthly web visits
83
Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

Total
30,000,000 (currency not stated)
Rounds
2
Latest round
Series unknown
Latest round date
Jan 2019
Investors
6
Lead investors
1
Listing status
private

About this record2 fields

Sources
crunchbase,country:domain-tld
Last imported
Sept 2026

Growth, as the source summarises it

Eywa Pharma may be growing as it has recently sold its oral solid dosage manufacturing facility in the US for $7.7 million. This transaction indicates a strategic move that could potentially be used to streamline operations or reinvest in other areas of the company. The sale of a manufacturing facility often suggests a consolidation of resources or a focus on other core competencies within the company's portfolio.

Companies like Eywa Pharma

Biotechnology in Singapore.

Build a lead list

55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.

Open the list